Health
Chronic kidney disease and the global public health agenda: an international consensus
World Health Organization. SDG target 3.4 non-communicable diseases and mental health. https://www.who.int/data/gho/data/themes/topics/sdg-target-3_4-noncommunicable-diseases-and-mental-health (2024).
World Health Organization. Non-communicable diseases. https://www.who.int/health-topics/noncommunicable-diseases#tab=tab_1 (2022).
Hsu, C. Y. et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 74, 101–107 (2008).
Coca, S. G., Singanamala, S. & Parikh, C. R. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 81, 442–448 (2012).
James, M. T. et al. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet 376, 2096–2103 (2010).
James, M. T. et al. A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury. Am. J. Kidney Dis. 66, 602–612 (2015).
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733 (2020).
Bikbov, B. Core global metrics of chronic kidney disease (CKD) mortality in the GBD 2019 study. Zenodo https://doi.org/10.5281/zenodo.8312881 (2023).
Jager, K. J. et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol. Dial. Transplant. 34, 1803–1805 (2019).
Bosi, A. et al. Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care. Clin. Kidney J. 15, 442–451 (2022).
Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2021 (US Department of Health and Human Services, 2021).
Gummidi, B. et al. A systematic study of the prevalence and risk factors of CKD in Uddanam, India. Kidney Int. Rep. 5, 2246–2255 (2020).
GBD. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1459–1544 (2016).
Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet 392, 2052–2090 (2018).
US National Institute of Diabetes and Digestive and Kidney Diseases. Kidney disease statistics for the United States. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease (2023).
Stanifer, J. W., Muiru, A., Jafar, T. H. & Patel, U. D. Chronic kidney disease in low- and middle-income countries. Nephrol. Dial. Transplant. 31, 868–874 (2016).
Mehta, R. L. et al. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet 387, 2017–2025 (2016).
Lewington, A. J., Cerdá, J. & Mehta, R. L. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int. 84, 457–467 (2013).
Olowu, W. A. et al. Outcomes of acute kidney injury in children and adults in sub-Saharan Africa: a systematic review. Lancet Glob. Health 4, e242–e250 (2016).
Jha, V. & Parameswaran, S. Community-acquired acute kidney injury in tropical countries. Nat. Rev. Nephrol. 9, 278–290 (2013).
Mehta, R. L. et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385, 2616–2643 (2015).
Liyanage, T. et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385, 1975–1982 (2015).
United States Renal Data System. 2022 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States (National Institute of Diabetes and Digestive and Kidney Diseases, 2022).
Bello, A. K. et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ 367, l5873 (2019).
Anand, S., Bitton, A. & Gaziano, T. The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS One 8, e72860 (2013).
Thomas, B. et al. Global cardiovascular and renal outcomes of reduced GFR. J. Am. Soc. Nephrol. 28, 2167–2179 (2017).
United Nations Department of Economic and Social Affairs, Population Division. World population prospects 2019: highlights. https://population.un.org/wpp/Publications/Files/WPP2019_Highlights.pdf (2019).
WDA Global Longevity Council. Living longer around the world: opportunities and challenges. https://www.wdaforum.org/fileadmin/ablage/wda_global_longevity_council/wda_paper_living__longer_around_the__world.pdf (2022).
Levey, A. S., Inker, L. A. & Coresh, J. Should the definition of CKD be changed to include age-adapted GFR criteria?”: con: the evaluation and management of CKD, not the definition, should be age-adapted. Kidney Int. 97, 37–40 (2020).
Hallan, S. I. et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 308, 2349–2360, (2012).
Ravani, P. et al. Association of age with risk of kidney failure in adults with stage IV chronic kidney disease in Canada. JAMA Netw. Open 3, e2017150–e2017150 (2020).
O’Sullivan, E. D., Hughes, J. & Ferenbach, D. A. Renal aging: causes and consequences. J. Am. Soc. Nephrol. 28, 407–420 (2017).
Ebert, T. et al. Inflammation and premature ageing in chronic kidney disease. Toxins 12, 227, (2020).
Kataria, A., Trasande, L. & Trachtman, H. The effects of environmental chemicals on renal function. Nat. Rev. Nephrol. 11, 610–625 (2015).
Wearne, N. & Okpechi, I. G. HIV-associated renal disease — an overview. Clin. Nephrol. 86, 41–47 (2016).
Hossain, M. P., Goyder, E. C., Rigby, J. E. & El Nahas, M. CKD and poverty: a growing global challenge. Am. J. Kidney Dis. 53, 166–174 (2009).
Shoham, D. A. et al. Kidney disease and the cumulative burden of life course socioeconomic conditions: the Atherosclerosis Risk in Communities (ARIC) study. Soc. Sci. Med 67, 1311–1320 (2008).
Akrawi, D. S., Li, X., Sundquist, J., Sundquist, K. & Zöller, B. End stage renal disease risk and neighbourhood deprivation: a nationwide cohort study in Sweden. Eur. J. Intern. Med. 25, 853–859 (2014).
Wyld, M. L. R. et al. Sex-based differences in risk factors and complications of chronic kidney disease. Semin. Nephrol. 42, 153–169 (2022).
Eneanya, N. D. et al. Health inequities and the inappropriate use of race in nephrology. Nat. Rev. Nephrol. 18, 84–94 (2022).
Barraclough, K. A., Blashki, G. A., Holt, S. G. & Agar, J. W. M. Climate change and kidney disease-threats and opportunities. Kidney Int. 92, 526–530 (2017).
Burkart, K. G. et al. Estimating the cause-specific relative risks of non-optimal temperature on daily mortality: a two-part modelling approach applied to the Global Burden of Disease Study. Lancet 398, 685–697 (2021).
Ebi, K. L. et al. Hot weather and heat extremes: health risks. Lancet 398, 698–708 (2021).
Rosinger, A. Y. et al. Drinking water salinity is associated with hypertension and hyperdilute urine among Daasanach pastoralists in Northern Kenya. Sci. Total. Environ. 770, 144667 (2021).
Wan, E. T., Darssan, D., Karatela, S., Reid, S. A. & Osborne, N. J. Association of pesticides and kidney function among adults in the US population 2001–2010. Int. J. Environ. Res. Public Health 18, 10249 (2021).
Gao, Z. et al. Toxic nephropathy secondary to chronic mercury poisoning: clinical characteristics and outcomes. Kidney Int. Rep. 7, 1189–1197 (2022).
Johnson, R. J., Wesseling, C. & Newman, L. S. Chronic kidney disease of unknown cause in agricultural communities. N. Engl. J. Med. 380, 1843–1852 (2019).
John, O. et al. Chronic kidney disease of unknown etiology in India: what do we know and where we need to go. Kidney Int. Rep. 6, 2743–2751 (2021).
Parameswaran, S. et al. A newly recognized endemic region of CKD of undetermined etiology (CKDu) in South India — “Tondaimandalam nephropathy”. Kidney Int. Rep. 5, 2066–2073 (2020).
Arora, S., Ps, P., Sahoo, J., Vairappan, B. & Parameswaran, S. Seasonal changes in kidney function in CKD of uncertain etiology. Kidney Int. Rep. 6, 2918–2921 (2021).
Wijewickrama, E. S. et al. Prevalence of CKD of unknown etiology and its potential risk factors in a rural population in Sri Lanka. Kidney Int. Rep. 7, 2303–2307 (2022).
Cabrera, J. W. et al. Chronic interstitial nephritis in agricultural communities: a patient in Paraguay. Kidney Int. Rep. 7, 1131–1135 (2022).
Talukder, M. R. R., Rutherford, S., Phung, D., Islam, M. Z. & Chu, C. The effect of drinking water salinity on blood pressure in young adults of coastal Bangladesh. Environ. Pollut. 214, 248–254 (2016).
Khan, J. R., Awan, N., Archie, R. J., Sultana, N. & Muurlink, O. The association between drinking water salinity and hypertension in coastal Bangladesh. Glob. Health J. 4, 153–158 (2020).
Khan, A. E. et al. Salinity in drinking water and the risk of (pre)eclampsia and gestational hypertension in coastal Bangladesh: a case-control study. PLoS One 9, e108715 (2014).
Blum, M. F. et al. Particulate matter and albuminuria, glomerular filtration rate, and incident CKD. Clin. J. Am. Soc. Nephrol. 15, 311–319 (2020).
Bowe, B. et al. Estimates of the 2016 global burden of kidney disease attributable to ambient fine particulate matter air pollution. BMJ Open 9, e022450 (2019).
He, P. et al. Higher ambient nitrogen dioxide is associated with an elevated risk of hospital-acquired acute kidney injury. Clin. Kidney J. 15, 95–100 (2021).
United Nations Convention to Combat Desertification. Drought in numbers 2022 — restoration for readiness and resilience. https://www.unccd.int/sites/default/files/2022-05/Drought%20in%20Numbers.pdf (2022).
Agar, J. W. M. & Barraclough, K. A. Water use in dialysis: environmental considerations. Nat. Rev. Nephrol. 16, 556–557 (2020).
Sekkarie, M., Hiracham, P., Soudan, K. & Rifai, A. O. Hemodialysis machines capable of performing isolated ultrafiltration in the absence of adequate water supply are needed during disasters. Kidney Int. Rep. 6, 1480–1481 (2021).
Isreb, M. A. et al. The effect of war on Syrian refugees with end-stage renal disease. Kidney Int. Rep. 2, 960–963 (2017).
Koubar, S. H., Hajj Nasan, K. & Sekkarie, M. A. K. Nephrology workforce and education in conflict zones. Kidney Int. Rep. 7, 129–132 (2022).
Sever, M. et al. The Marmara earthquake: epidemiological analysis of the victims with nephrological problems. Kidney Int. 60, 1114–1123 (2001).
Luyckx, V. A. & Brenner, B. M. Birth weight, malnutrition and kidney-associated outcomes — a global concern. Nat. Rev. Nephrol. 11, 135–149 (2015).
Wilding, S. et al. Are socioeconomic inequalities in the incidence of small-for-gestational-age birth narrowing? Findings from a population-based cohort in the South of England. BMJ Open 9, e026998 (2019).
Hoy, W. E., Swanson, C. E. & Mott, S. A. Birthweight and the prevalence, progression, and incidence of CKD in a multideterminant model in a high-risk Australian aboriginal community. Kidney Int. Rep. 6, 2782–2793 (2021).
Gjerde, A., Skrunes, R., Reisæter, A. V., Marti, H.-P. & Vikse, B. E. Familial contributions to the association between low birth weight and risk of CKD in adult life. Kidney Int. Rep. 6, 2151–2158 (2021).
Lillås, B. S., Qvale, T. H., Richter, B. K. & Vikse, B. E. Birth weight is associated with kidney size in middle-aged women. Kidney Int. Rep. 6, 2794–2802 (2021).
Hsu, C. W., Yamamoto, K. T., Henry, R. K., De Roos, A. J. & Flynn, J. T. Prenatal risk factors for childhood CKD. J. Am. Soc. Nephrol. 25, 2105–2111 (2014).
Crump, C., Sundquist, J., Winkleby, M. A. & Sundquist, K. Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood: national cohort study. BMJ 365, l1346 (2019).
Sanderson, K. R. et al. Albuminuria, hypertension, and reduced kidney volumes in adolescents born extremely premature. Front Pediatr. 8, 230 (2020).
Hingorani, S. et al. Prevalence and risk factors for kidney disease and elevated BP in 2-year-old children born extremely premature. Clin. J. Am. Soc. Nephrol. 17, 1129–1138 (2022).
Luyckx, V. A. et al. A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group. Lancet 390, 424–428 (2017).
Guo, Q., Wu, S., Xu, C., Wang, J. & Chen, J. Global disease burden from acute glomerulonephritis 1990–2019. Kidney Int. Rep. 6, 2212–2217 (2021).
Cerdá, J. et al. Acute kidney injury recognition in low- and middle-income countries. Kidney Int. Rep. 2, 530–543 (2017).
Kashani, K. et al. Acute kidney injury risk assessment: differences and similarities between resource-limited and resource-rich countries. Kidney Int. Rep. 2, 519–529 (2017).
Smoyer, W. E. et al. Saving young lives with acute kidney injury: the challenge of acute dialysis in low-resource settings. Kidney Int. 89, 254–256 (2016).
Yang, C. W. Leptospirosis renal disease: emerging culprit of chronic kidney disease unknown etiology. Nephron 138, 129–136 (2018).
Phannajit, J. et al. Long-term kidney outcomes after leptospirosis: a prospective multicenter cohort study in Thailand. Nephrol. Dial. Transplant. 38, 2182–2191 (2023).
Riefkohl, A. et al. Leptospira seropositivity as a risk factor for Mesoamerican nephropathy. Int. J. Occup. Environ. Health 23, 1–10 (2017).
Martins, D. et al. The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III). Am. J. Kidney Dis. 47, 965–971 (2006).
Drey, N., Roderick, P., Mullee, M. & Rogerson, M. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am. J. Kidney Dis. 42, 677–684 (2003).
Morton, R. L. et al. Impact of CKD on household income. Kidney Int. Rep. 3, 610–618 (2018).
Chesnaye, N. C., Carrero, J. J., Hecking, M. & Jager, K. J. Differences in the epidemiology, management and outcomes of kidney disease in men and women. Nat. Rev. Nephrol. 20, 7–20 (2024).
Melsom, T. et al. Sex differences in age-related loss of kidney function. J. Am. Soc. Nephrol. 33, 1891–1902 (2022).
van der Burgh, A. C., Rizopoulos, D., Ikram, M. A., Hoorn, E. J. & Chaker, L. Determinants of the evolution of kidney function with age. Kidney Int. Rep. 6, 3054–3063 (2021).
Ritchie, H. Causes of death. Our World in Data https://ourworldindata.org/does-the-news-reflect-what-we-die-from (2019).
Tummalapalli, S. L. et al. Availability and affordability of kidney health laboratory tests around the globe. Am. J. Nephrol. 51, 959–965 (2020).
Talbot, B., Athavale, A., Jha, V. & Gallagher, M. Data challenges in addressing chronic kidney disease in low- and lower-middle-income countries. Kidney Int. Rep. 6, 1503–1512 (2021).
Ng, M. S. Y., Charu, V., Johnson, D. W., O’Shaughnessy, M. M. & Mallett, A. J. National and international kidney failure registries: characteristics, commonalities, and contrasts. Kidney Int. 101, 23–35 (2022).
Davids, M. R. et al. A renal registry for Africa: first steps. Clin. Kidney J. 9, 162–167 (2015).
Luxardo, R., Ceretta, L., González-Bedat, M., Ferreiro, A. & Rosa-Diez, G. The Latin American Dialysis and Renal Transplantation Registry: report 2019. Clin. Kidney J. 15, 425–431 (2021).
Bello, A.K. et al. ISN — global kidney health atlas: a report by the International Society of Nephrology: an assessment of global kidney health care status focussing on capacity, availability, accessibility, affordability and outcomes of kidney disease. (International Society of Nephrology, 2023).
Bello, A. K. et al. Global overview of health systems oversight and financing for kidney care. Kidney Int. Suppl. 8, 41–51 (2018).
Narva, A. S. et al. Toward a more collaborative federal response to chronic kidney disease. Adv. Chronic kidney Dis. 17, 282–288 (2010).
European Commission. Healthier together — EU non-communicable diseases initiative. https://health.ec.europa.eu/system/files/2022-06/eu-ncd-initiative_publication_en_0.pdf (2022).
Shlipak, M. G. et al. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 99, 34–47 (2021).
World Health Organization. The top 10 causes of death. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (2020).
Boenink, R. et al. The ERA registry annual report 2019: summary and age comparisons. Clin. Kidney J. 15, 452–472 (2022).
Zoccali, C. et al. The systemic nature of CKD. Nat. Rev. Nephrol. 13, 344–358 (2017).
Vos, T. et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204–1222 (2020).
Xie, Y. et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 94, 567–581 (2018).
Kalantar-Zadeh, K. et al. Patient-centred approaches for the management of unpleasant symptoms in kidney disease. Nat. Rev. Nephrol. 18, 185–198 (2022).
Fletcher, B. R. et al. Symptom burden and health-related quality of life in chronic kidney disease: a global systematic review and meta-analysis. PLOS Med. 19, e1003954 (2022).
Francis, A. et al. Quality of life of children and adolescents with chronic kidney disease: a cross-sectional study. Arch. Dis. Child 104, 134–140 (2019).
Chesnaye, N. C. et al. Health-related quality-of-life trajectories over time in older men and women with advanced chronic kidney disease. Clin. J. Am. Soc. Nephrol. 17, 205–214 (2022).
de Rooij, E. N. M. et al. Quality of life before and after the start of dialysis in older patients. Clin. J. Am. Soc. Nephrol. 17, 1159–1167 (2022).
de Rooij, E. N. M. et al. Symptom burden before and after dialysis initiation in older patients. Clin. J. Am. Soc. Nephrol. 17, 1719–1729 (2022).
Mahmoud, D. A. M., Saad, A., Abdelhamid, Y. H. & El Hawary, Y. Depression and psychosocial burden among caregivers of children with chronic kidney disease. Middle East Curr. Psychiatry 28, 12 (2021).
Pereira, Bd. S. et al. Beyond quality of life: a cross sectional study on the mental health of patients with chronic kidney disease undergoing dialysis and their caregivers. Health Qual. Life Outcomes 15, 74 (2017).
Shukri, M., Mustofai, M. A., Md Yasin, M. A. S. & Tuan Hadi, T. S. Burden, quality of life, anxiety, and depressive symptoms among caregivers of hemodialysis patients: the role of social support. Int. J. Psychiatry Med. 55, 397–407 (2020).
Adejumo, O. A., Iyawe, I. O., Akinbodewa, A. A., Abolarin, O. S. & Alli, E. O. Burden, psychological well-being and quality of life of caregivers of end stage renal disease patients. Ghana Med. J. 53, 190–196, (2019).
Luyckx, V. A., Tonelli, M. & Stanifer, J. W. The global burden of kidney disease and the sustainable development goals. Bull. World Health Organ. 96, 414–422 (2018).
World Health Organization. Global health estimates: leading causes of death. Cause-specific mortality, 2000–2019. Global Health Observatory https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death (2020).
Tonelli, M. et al. Chronic kidney disease and mortality risk: a systematic review. J. Am. Soc. Nephrol. 17, 2034–2047 (2006).
Francis, A., Baigent, C., Ikizler, T. A., Cockwell, P. & Jha, V. The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action. Kidney Int. 99, 791–793 (2021).
McDonald, H. I., Thomas, S. L. & Nitsch, D. Chronic kidney disease as a risk factor for acute community-acquired infections in high-income countries: a systematic review. BMJ Open 4, e004100 (2014).
Tanaka, S. & Okusa, M. D. Crosstalk between the nervous system and the kidney. Kidney Int. 97, 466–476 (2020).
Rangaswami, J. et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 139, e840–e878 (2019).
Husain-Syed, F., Slutsky, A. S. & Ronco, C. Lung-kidney cross-talk in the critically ill patient. Am. J. Respir. Crit. Care Med. 194, 402–414 (2016).
Visseren, F. L. J. et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the task force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC). Eur. Heart J. 42, 3227–3337 (2021).
Ortiz, A., Wanner, C. & Gansevoort, R. Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association. Eur. J. Prev. Cardiol. 29, 2211–2215 (2022).
Kerr, M., Bray, B., Medcalf, J., O’Donoghue, D. J. & Matthews, B. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol. Dial. Transplant. 27 (Suppl. 3), 73–80 (2012).
Vanholder, R. et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat. Rev. Nephrol. 13, 393–409 (2017).
Shaikh, M. et al. Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India. Kidney Int. 94, 440–445 (2018).
Tonelli, M. et al. Comparison of the complexity of patients seen by different medical subspecialists in a universal health care system. JAMA Netw. Open 1, e184852–e184852 (2018).
Vanholder, R. et al. Fighting the unbearable lightness of neglecting kidney health: the decade of the kidney. Clin. Kidney J. 14, 1719–1730 (2021).
Riaz, P. et al. Workforce capacity for the care of patients with kidney failure across world countries and regions. BMJ Glob. Health 6, e004014 (2021).
Lalji, R. et al. Disparities in end-stage kidney disease care for children: a global survey. Kidney Int. 98, 527–532 (2020).
Essue, B. M. et al. In Disease Control Priorities: Improving Health and Reducing Poverty (eds Jamison, D. T. et al.) (The International Bank for Reconstruction and Development/The World Bank, 2017).
Kim, S. et al. Cognitive and academic outcomes in children with chronic kidney disease. Pediatr. Nephrol. 37, 2715–2724 (2022).
Khalid, R. et al. Association between socioeconomic status and academic performance in children and adolescents with chronic kidney disease. Pediatr. Nephrol. 37, 3195–3204 (2022).
Erickson, K. F., Zhao, B., Ho, V. & Winkelmayer, W. C. Employment among patients starting dialysis in the United States. Clin. J. Am. Soc. Nephrol. 13, 265–273 (2018).
Vollset, S. E. et al. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study. Lancet 396, 1285–1306 (2020).
Htay, H. et al. Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project. Kidney Int. Suppl. 8, 64–73 (2018).
Levin A, S. P. et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 3, 1–150 (2013).
Li, P. K.-T. et al. Kidney health for everyone everywhere — from prevention to detection and equitable access to care. Kidney Int. Rep. 5, 245–251 (2020).
Francis, A. et al. Barriers to accessing essential medicines for kidney disease in low and low middle income countries. Kidney Int. 5, 969–973 (2022).
Thurlow, J. S. et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am. J. Nephrol. 52, 98–107 (2021).
Alencar de Pinho, N. et al. Understanding international variations in kidney failure incidence and initiation of replacement therapy. Kidney Int. Rep. 7, 2364–2375 (2022).
Tang, S. C. W. et al. Dialysis care and dialysis funding in Asia. Am. J. Kidney Dis. 75, 772–781 (2020).
Lalji, R., Francis, A., Johnson, D. W. & McCulloch, M. Health disparities in access to kidney replacement therapy amongst children and adolescents with end-stage kidney disease in low- and lower-middle-income countries. Kidney Int. 97, 463–465 (2020).
Ashuntantang, G. et al. Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review. Lancet Glob. Health 5, e408–e417 (2017).
Gonzalez-Bedat, M. C. et al. Burden of disease: closing the gaps in the burden of end-stage kidney disease in Latin America. Clin. Nephrol. 93, 55–59 (2020).
Baigent, C. et al. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet 400, 1788–1801 (2022).
Stanifer, J. W. et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: aasystematic review and meta-analysis. Lancet Glob. Health 2, e174–e181 (2014).
Hole, B. D. et al. International collaborative efforts to establish kidney health surveillance systems. Kidney Int. 98, 812–816 (2020).
Gutierrez-Peña, M. et al. High prevalence of end-stage renal disease of unknown origin in Aguascalientes Mexico: role of the registry of chronic kidney disease and renal biopsy in its approach and future directions. Clin. Kidney J. 14, 1197–1206 (2021).
Salas, R. N., Maibach, E., Pencheon, D., Watts, N. & Frumkin, H. A pathway to net zero emissions for healthcare. BMJ 371, m3785 (2020).
Sehgal, A. R., Slutzman, J. E. & Huml, A. M. Sources of variation in the carbon footprint of hemodialysis treatment. J. Am. Soc. Nephrol. 33, 1790–1795 (2022).
Rao, N., Rajan, T. & Stigant, C. Quantification of recyclable peritoneal dialysis plastics in a home dialysis program — an opportunity for resource stewardship. Kidney Int. Rep. 8, 365–367 (2020).
Bendine, G. et al. Haemodialysis therapy and sustainable growth: a corporate experience in France. Nephrol. Dial. Transplant. 35, 2154–2160 (2020).
|
Sources 2/ https://www.nature.com/articles/s41581-024-00820-6 The mention sources can contact us to remove/changing this article |
What Are The Main Benefits Of Comparing Car Insurance Quotes Online
LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: [email protected]: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos
to request, modification Contact us at Here or [email protected]
 |
 |
 |
